These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7539936)

  • 1. Natural protection against HIV-1 infection provided by HIV-2.
    Travers K; Mboup S; Marlink R; Guèye-Nidaye A; Siby T; Thior I; Traore I; Dieng-Sarr A; Sankalé JL; Mullins C
    Science; 1995 Jun; 268(5217):1612-5. PubMed ID: 7539936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can one type of HIV protect against another type?
    Cohen J
    Science; 1995 Jun; 268(5217):1566. PubMed ID: 7777855
    [No Abstract]   [Full Text] [Related]  

  • 3. Slower heterosexual spread of HIV-2 than HIV-1.
    Kanki PJ; Travers KU; MBoup S; Hsieh CC; Marlink RG; Gueye-NDiaye A; Siby T; Thior I; Hernandez-Avila M; Sankalé JL
    Lancet; 1994 Apr; 343(8903):943-6. PubMed ID: 7909009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.
    Popper SJ; Sarr AD; Travers KU; Guèye-Ndiaye A; Mboup S; Essex ME; Kanki PJ
    J Infect Dis; 1999 Oct; 180(4):1116-21. PubMed ID: 10479138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal.
    Gilbert PB; McKeague IW; Eisen G; Mullins C; Guéye-NDiaye A; Mboup S; Kanki PJ
    Stat Med; 2003 Feb; 22(4):573-93. PubMed ID: 12590415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cytotoxic T-cells in HIV infection.
    Rowland-Jones S; Dong T; Krausa P; Sutton J; Newell H; Ariyoshi K; Gotch F; Sabally S; Corrah T; Kimani J; MacDonald K; Plummer F; Ndinya-Achola J; Whittle H; McMichael A
    Dev Biol Stand; 1998; 92():209-14. PubMed ID: 9554277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced rate of disease development after HIV-2 infection as compared to HIV-1.
    Marlink R; Kanki P; Thior I; Travers K; Eisen G; Siby T; Traore I; Hsieh CC; Dia MC; Gueye EH
    Science; 1994 Sep; 265(5178):1587-90. PubMed ID: 7915856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Interaction With Human Host: HIV-2 As a Model of a Less Virulent Infection.
    Azevedo-Pereira JM; Santos-Costa Q
    AIDS Rev; 2016; 18(1):44-53. PubMed ID: 26936760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T-cell recognition of HIV proteins and peptides.
    Nixon DF; McMichael AJ
    AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.
    Fowke KR; Nagelkerke NJ; Kimani J; Simonsen JN; Anzala AO; Bwayo JJ; MacDonald KS; Ngugi EN; Plummer FA
    Lancet; 1996 Nov; 348(9038):1347-51. PubMed ID: 8918278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against HIV infection: lessons from HIV-2 infection.
    Rowland-Jones S
    Future Microbiol; 2006 Dec; 1(4):427-33. PubMed ID: 17661633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: no protection of HIV-2 against HIV-1 infection.
    Norrgren H; Andersson S; Biague AJ; da Silva ZJ; Dias F; Nauclér A; Biberfeld G
    AIDS; 1999 Apr; 13(6):701-7. PubMed ID: 10397565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
    Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ
    J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for HIV infection in people attending clinics for sexually transmitted diseases in India.
    Rodrigues JJ; Mehendale SM; Shepherd ME; Divekar AD; Gangakhedkar RR; Quinn TC; Paranjape RS; Risbud AR; Brookmeyer RS; Gadkari DA
    BMJ; 1995 Jul; 311(7000):283-6. PubMed ID: 7633230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positivity of HIV-2 immunoblots in a cohort of elite suppressors infected with HIV-1.
    McKellar MS; Jongthavorn P; Khanlou H
    J Acquir Immune Defic Syndr; 2008 Apr; 47(5):644. PubMed ID: 18362696
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for HIV-1 seroconversion among young men in northern Thailand.
    Celentano DD; Nelson KE; Suprasert S; Eiumtrakul S; Tulvatana S; Kuntolbutra S; Akarasewi P; Matanasarawoot A; Wright NH; Sirisopana N
    JAMA; 1996 Jan; 275(2):122-7. PubMed ID: 8531307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-2 and natural protection against HIV-1 infection.
    Greenberg AE; Wiktor SZ; DeCock KM; Smith P; Jaffe HW; Dondero TJ
    Science; 1996 Jun; 272(5270):1959-60. PubMed ID: 8658172
    [No Abstract]   [Full Text] [Related]  

  • 18. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences of HIV envelope protein between HIV-1 and HIV-2: possible relation to the lower virulence of HIV-2.
    Sekigawa I; Kaneko H; Neoh LP; Takeda-Hirokawa N; Akimoto H; Hishikawa T; Hashimoto H; Hirose S; Yamamoto N; Kaneko Y
    Viral Immunol; 1998; 11(1):1-8. PubMed ID: 9586692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.